Bulk Rituximab Monoclonal Antibody
Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If modified or obtained differently without biotech process
Other immunological products not unmixed go to 3002.90.
If part of mixed therapeutic preparations
Mixed products classify under 3004 per chapter note 3.
If for specific diagnostic immunosera
Diagnostic reagents excluded to 3822.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Ensure BLA (Biologics License Application) reference; provide glycosylation profile analysis; declare bulk quantity to affirm non-retail status
Related Products under HTS 3002.13.00
Unmixed Monoclonal Antibody Bevacizumab
Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF) for use in cancer therapy. It falls under HTS 3002.13.00 as an unmixed immunological product, not put up in measured doses or retail packings, consistent with chapter note definitions for immunological products like monoclonal antibodies directly involved in immunological regulation. Supplied in bulk liquid form for pharmaceutical compounding.
Bulk Interferon Alpha-2a
Interferon Alpha-2a is a cytokine protein used for antiviral and anticancer treatment, produced via recombinant DNA technology. Classified under HTS 3002.13.00 as an unmixed immunological product per chapter notes, supplied in bulk vials without measured doses or retail packaging for further formulation.
Recombinant Interleukin-2 (IL-2)
IL-2 is a growth factor protein stimulating immune cell proliferation, used in immunotherapy for cancer. It qualifies as an unmixed immunological product under HTS 3002.13.00, not in retail forms, matching chapter note for interleukins regulating immunological processes.
Unmixed Tumor Necrosis Factor Alpha (TNF-α)
TNF-α is a cytokine involved in systemic inflammation and immune regulation, supplied in bulk for research and therapeutic development. HTS 3002.13.00 applies to this unmixed immunological product per chapter definitions for TNFs.
Recombinant Erythropoietin (EPO)
EPO is a glycoprotein hormone stimulating red blood cell production, with immunological regulatory roles. Bulk unmixed form classifies under HTS 3002.13.00 as per immunological product notes.
Unmixed Adalimumab Biosimilar
Adalimumab biosimilar is a TNF inhibitor monoclonal antibody for rheumatoid arthritis. Supplied unmixed in bulk, it meets HTS 3002.13.00 for immunological products.